Huawei ICT Academy Advisory Board Leads the Way in Securing the ICT Talent Ecosystem for the Future
There is a crisis emerging in the ICT industry, as the sector struggles to fill vital roles. Talent supply is the top problem facing digital tech businesses in the UK, according to Technation. As technology evolves, experienced staff retire, and more jobs become available, this problem is set to get worse. In fact, there are predicted to be 1.7 million new ICT jobs for tech specialists between 2015 and 2025, and candidates need the skills and experience to fill them.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180508005796/en/
Professor Zhili Sun, Vice-Chair Academia of the Huawei ICT Academy Advisory Board (Photo: Business Wire)
To help solve this problem, Huawei ICT Academy provides a not-for-profit education initiative that facilitates partnerships between universities and business, supporting young Europeans with great potential in digital, such as students, developers and entrepreneurs. The Huawei ICT Academy Advisory Board was established in November 2017 to lead the Huawei ICT Academy in Western Europe and runs independently, supported by investment from Huawei. It is Huawei’s only association of this type outside China. The Board leads the overall direction and development of the Huawei ICT Academy and supports the industry in furthering practitioner knowledge.
The Huawei ICT Academy Advisory Board is made up of renowned academics, members of professional bodies and leaders from Huawei. It ensures that the Huawei ICT Academy provides a platform for academic excellence and challenges students and developers with competitions and certifications, helping its audience of New Young Europeans to have successful ICT roles in the future.
Professor Zhili Sun, Vice-Chair Academia of the Huawei ICT Academy Advisory Board, and professor of Communication Networking at the University of Surrey, said: “We set up a committee to serve the group of young talented people involved in skills within the UK and Europe.”
The board is led by Professor Edmund Burke, Chair – Academia and Vice Principal for Science and Engineering at Queen Mary University, London. His Co-Chair is Mr. Bradd Feng, Director of Global Training and Certification Dept. at Huawei. Together they lead the 20 board members who oversee the Huawei ICT Academy’s programs, processes, delivery and organization and lead on the strategic development of the Huawei ICT Academy Program in the UK.
For example, Huawei and Huawei ICT Academy organise the Huawei ICT Skill Competition to develop ICT professionals, connecting with the makers and doers of the digital future. The global final of the competition takes place in China in May, with six students from Western Europe competing. They will learn relevant skills and gain experience that will power the entire industry and, ultimately, drive digital transformation. Huawei also works with governments, offers globally recognised certifications, graduate programs and joint R&D projects to help build an open, sustainable ICT ecosystem.
By bringing together leaders from academia and industry, the Advisory Board’s leadership will further the development of the ICT Industry by providing advice on issues of strategic importance, such as the syllabus, virtual learning resources, program delivery and processes. Technology advances come rapidly in the ICT sector, so by overseeing the direction of the ICT Academy Programme, the Advisory Board ensures that students are developing vital knowledge to become a new type of multi-skilled engineer – critical to the ICT industry as well as to global development and growth.
This will continue to have a positive impact when students enter the workplace. Pearson VUE’s 2017 Value of Certification Survey found that 54% of people experienced their first benefit within three months of gaining a certification, such as a salary increase or promotion. Additionally, 93% of hiring managers recognise industry certifications.
Huawei ICT Academy
Huawei ICT Academy is a not-for-profit education program that facilitates university-enterprise partnerships. The project aims to lead ICT development, build the future of the ICT industry, and create a sound talent ecosystem by providing ICT education worldwide. To date, Huawei has fostered cooperation with more than 300 universities in Europe, North America, Southeast Asia, Australia, and other regions around the world. In the future, Huawei will hold higher education development summit forums and forge ICT talent alliances to further drive the healthy, sustainable, and efficient development of the ICT talent ecosystem.
Huawei ICT Academy
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Ultra-Low Power Lattice sensAI Leads Mass Market Enablement of Artificial Intelligence in Edge Devices21.5.2018 15:00 | Tiedote
Lattice Semiconductor Corporation (NASDAQ: LSCC) today unveiled Lattice sensAI™ – a complete technology stack combining modular hardware kits, neural network IP cores, software tools, reference designs and custom design services – to accelerate integration of machine learning inferencing into broad market IoT applications. With solutions optimized for ultra-low power consumption (under 1 mW–1 W), small package size (5.5 mm2 –100 mm2), interface flexibility (MIPI® CSI-2, LVDS, GigE, etc.), and high-volume pricing (~$1-$10 USD), Lattice sensAI stack fast-tracks implementation of edge computing close to the source of data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180521005011/en/ (Graphic: Business Wire) “Lattice sensAI addresses the unmet need for flexible, low cost, ultra-low power AI silicon solutions suited for rapid deployment across a wide range of emerging, mass market IoT applications,” said Deepak Boppana, senior
NioCorp Awards Contract to Rockwell Automation on Groundbreaking Critical Minerals, Mining and Processing Facility in Nebraska21.5.2018 15:00 | Tiedote
NioCorp Developments Ltd. (TSX: NB, OTCQX: NIOBF), a developer of superalloy metals, has awarded a major contract to Rockwell Automation (NYSE: ROK) to engineer, design and procure process automation and instrumentation for NioCorp’s proposed critical minerals, mining and processing facility in Elk Creek, Nebraska. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180521005228/en/ Three superalloy metals – niobium, scandium and titanium – are expected to be produced by the facility as early as 2021. These critical materials are used in the aerospace, defense, automotive, clean energy, commercial aviation and mega-infrastructure sectors. Generally, these superalloys enable increased strength and lighter weight in transportation and other systems, leading to better fuel efficiency and lower greenhouse gas and other air emissions, according to NioCorp. “We selected Rockwell Automation and its partners to automate our process equip
Biosimilars could facilitate early access to life changing biological treatments for patients says Celltrion Healthcare21.5.2018 14:27 | Tiedote
At the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 23rd Annual International Meeting in Baltimore, Celltrion Healthcare today advocated for healthcare systems to introduce biologics earlier in a patient’s treatment regimen in order to improve clinical outcomes. Several studies show that the early introduction of biologics can bring greater clinical benefit to patients.1,2,3,4,5,6 However, only a limited number of patients have access to biological treatment due to the high-cost of biologics and current reimbursement policies determined by pharmacoeconomic evaluations. Since the introduction of biosimilars, the overall cost of biological treatments has reduced in Europe, allowing an increased number of patients to access this important treatment option earlier in their course of treatment.7 Professor Jørgen Jahnsen said, “For the treatment of inflammatory bowel disease, biological treatments are proven to be the most efficacious medical therapy and their ea
Dole’s Joint Venture Recycling Company Celebrates 25 Years21.5.2018 14:00 | Tiedote
Dole Food Company announced today that Recyplast S.A., an innovative plastic recycling company based in Costa Rica and with joint ownership including a subsidiary of Dole Fresh Fruit, recently surpassed 25 years in its mission to dramatically reduce and reuse agricultural waste. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180521005160/en/ Raul Martinez (right), General Manager of Dole Standard Fruit de Costa Rica, receives a plaque from Jose Miguel Ramirez, General Manager of Recyplast, in recognition of the contribution of Dole's banana plantations in the correct handling, storage, and provision of field plastic waste. The plastic recycling facility pioneered the collection of field plastics after use in banana growing operations in Costa Rica. This reuse and recycling process includes reclamation of plastic bags that protect bananas from weather and insects, as well as the collection of plastic twine used to prop the ba
ViiV Healthcare Receives EU Marketing Authorisation for Juluca (dolutegravir/rilpivirine), the First 2-Drug Regimen, Once-Daily, Single-Pill for the Treatment of HIV21.5.2018 13:11 | Tiedote
ViiV Healthcare, the global specialist HIV company, majority owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the European Commission has granted marketing authorisation for Juluca (dolutegravir 50mg/rilpivirine 25mg) for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 copies/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor or integrase inhibitor.1 Juluca is a 2-drug regimen of dolutegravir (ViiV Healthcare), the most widely prescribed integrase inhibitor worldwide,2 and rilpivirine (Janssen Sciences Ireland UC, part of the Janssen Pharmaceutical Companies of Johnson & Johnson).1 Deborah Waterhouse, CEO ViiV Healthcare said, “The European Commission Decision for Juluca is very positive news for people living with
Janssen Announces European Commission Approval of JULUCA®▼ (dolutegravir/rilpivirine), the First Two-Drug Regimen, Once-Daily, Single-Pill for the Treatment of HIV-121.5.2018 13:06 | Tiedote
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the European Commission has granted marketing authorisation for JULUCA® (dolutegravir 50mg [ViiV Healthcare]/rilpivirine 25mg [Janssen Sciences Ireland UC]).1 ViiV Healthcare, as the marketing authorisation holder, will market dolutegravir/rilpivirine in all countries in the European Union and European Economic Area. Dolutegravir/rilpivirine is the first two-drug regimen, once-daily, single-pill for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase inhibitor (INI).1 “The European Commission Decision for dolutegravir/rilpivirine marks a significant milestone in our 25-year commitment to make HIV history,” said Brian Woo
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme